Quote from CEO"After spending much of the past year assembling our team and developing our technology driven processes we are excited to be moving the Company forward towards providing a premium quality medical marijuana product to Canadian patients under the MMPR. Our pharmaceutical grade approach aims to ensure repeatable, scalable and consistent medical marijuana products," said Rob Gagnon, founder of Thunderbird and CEO of T-Bird. "Over the next few months we will be working towards further expansion of not only our growing facilities, but also adding key scientific advisors to our team".